Does DOSTARLIMAB Cause Platelet count decreased? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Platelet count decreased have been filed in association with DOSTARLIMAB (Jemperli). This represents 1.3% of all adverse event reports for DOSTARLIMAB.
12
Reports of Platelet count decreased with DOSTARLIMAB
1.3%
of all DOSTARLIMAB reports
1
Deaths
8
Hospitalizations
How Dangerous Is Platelet count decreased From DOSTARLIMAB?
Of the 12 reports, 1 (8.3%) resulted in death, 8 (66.7%) required hospitalization, and 5 (41.7%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOSTARLIMAB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does DOSTARLIMAB Cause?
Malignant neoplasm progression (111)
Thrombocytopenia (42)
Fatigue (38)
Anaemia (36)
Death (31)
Arthralgia (30)
Diarrhoea (29)
Rash (29)
Condition aggravated (27)
Dyspnoea (26)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which DOSTARLIMAB Alternatives Have Lower Platelet count decreased Risk?
DOSTARLIMAB vs DOSTARLIMAB-GXLY
DOSTARLIMAB vs DOTATATE GALLIUM GA-68
DOSTARLIMAB vs DOTHIEPIN
DOSTARLIMAB vs DOXAZOSIN
DOSTARLIMAB vs DOXAZOSIN\DOXAZOSIN